| کلیدواژههای انگلیسی مقاله |
Candida, Streptococcus salivarius, Probiotics, Biofilms, What&,rsquo s Known Interaction between probiotic bacteria and the fungal members of oral microbiota can influence the virulence of pathogens, which is beneficial to the host. Probiotics such as Lactobacillus species and Streptococcus salivarius could protect immunosuppressed-mice from candidiasis. What&,rsquo s New Streptococcus thermophilus successfully inhibited the growth, germination, and biofilm formation of Candida albicans. Moreover, this bacterium reduced Candida colonization and fungal burden on mucosal surfaces and relieved the signs and symptoms of oral candidiasis in our experimental model. IntroductionAccording to the definition of the World Health Organization/Food and Agriculture Organization, probiotics are &,ldquo live microorganisms that, when administered or consumed in adequate quantities, confer health benefits on the host&,rdquo . 1, While the Enterococcus, Streptococcus, Lactococcus, Pediococcus, and Saccharomyces genera have probiotic strains, most probiotic bacteria belong to the Lactobacillus and Bifidobacterium genera. 2, The mechanisms of probiotic actions in the oral cavity can be classified into three groups, normalization of the oral microbiota, modulation of the immune system, and metabolic effects. 3, Several studies have shown that probiotic bacteria may have a role in modulating oral fungal flora. 4, For example, an in vitro study of Lactobacilli species showed various inhibitory activities against oral candidiasis, with Lactobacillus rhamnosus (L. rhamnosus) GG having the strongest inhibitory effect. 5, Likewise, in a randomized clinical trial, a significant reduction in the number of Candida cells was observed in the cases fed with L. reuteri. 6, Moreover, it has been shown that the consumption of yogurt enriched with L. casei and Bifidobacterium breve increases secretory of IgA levels in saliva and causes a significant reduction in the Candida species population in the oral cavity of elderlies. 7, In an animal model study, Streptococcus salivarius (S salivarius) K12 significantly inhibited the adhesion and invasion of Candida albicans (C. albicans) into oral mucosal surfaces, and protected the mice from oral candidiasis. 8, Streptococcus salivarius subspecies thermophilus (S. thermophilus), as a part of the Streptococcaceae family, is a Gram-positive, fermentative, and facultative anaerobe bacterium of the viridans and lactic acid bacteria group. 9, It belongs to the S. salivarius strain, which has been reported to inhibit the biofilm formation of S. mutans, one of the etiological factors of dental caries. 10, This bacterium possesses the qualified presumption of safety (Q.P.S.), and is generally recognized as safe (G.R.A.S.) status due to a long history of safe use. 11, After Lactococcus lactis, this bacterium is considered to be the second most important starter in the dairy industry and is also known for folate production, a component involved in many metabolic reactions as a cofactor, including the biosynthesis of DNA and RNA. Furthermore, it has been reported that the consumption of this bacterium in sufficient amounts can have beneficial effects on human health such as producing antioxidants and vitamins, enhancing the immune system, and improving lactose digestion in lactose-intolerant individuals. 11, Candidiasis, as one of the most frequent fungal infections, can manifest in various forms such as cutaneous candidiasis, onychomycosis, mucosal involvement (oral, esophageal, gastrointestinal, and vaginal), and eventually systemic and life-threatening infections. 12, Oral candidiasis, as the most common form of this infection, is usually accompanied by severe inflammation, pain, and dysphasia and may be presented in three types, erythematous, pseudomembranous, and hyperplastic. 13, It is more prevalent in patients with acquired immunodeficiency syndrome (AIDS), diabetes mellitus, and xerostomia, as well as in individuals wearing dentures, patients under treatment with broad-spectrum antibiotics and immunosuppressive drugs, and individuals with poor oral hygiene. 13, Candida genus yeasts, the causative agents of candidiasis, are part of the normal flora of mucosal membranes and may transform into a pathogenic hyphal form under specific conditions. In most cases, the organisms isolated from the clinical cases of oral candidiasis are of the C. albicans complex, which consists of C. albicans, C. dubliniensis, and C. africana. 14, Phenotypic switching and transition from yeast to the filamentous form are of the main virulence factors of C. albicans. 15, Moreover, the ability to adhere and form a biofilm on different surfaces and to secrete degradative enzymes is an additional factor associated with candidiasis. 16, Since Candida biofilms include a dense matrix of yeast cells and commensal bacteria, their physical proximity in biofilm structures or on mucosal surfaces makes their interactions possible through various secondary metabolites or microbial secretions. 17, , 18, In this regard, numerous investigations have demonstrated that oral bacterial flora may play a significant role in the pathogenesis of C. albicans. 19, For instance, it was found that the coaggregation of C. albicans and S. gordonii, a normal inhabitant of the oral cavity, contributed to C. albicans survival and persistence through enhancing its growth, biofilm formation, and tissue invasion. 20, Nonetheless, an antagonistic interaction between Candida and Lactobacilli has been reported by previous studies, such that Lactobacilli inhibit C. albicans through reducing its growth, proliferation, adhesion, and hyphal formation through outcompeting for adhesion sites, secreting biosurfactants, and bacteriocin-like substances. 21, , 22, Since, a bacterial population may indirectly or directly influence the Candida population, 23, restoring the microbial balance by probiotic bacteria can be considered a novel therapeutic method for the prevention or even treatment of oral candidiasis. 24, Given the strain-dependency of probiotic properties and limited information on the interaction between S. thermophilus and Candida yeasts, we investigated the effect of this probiotic bacterium on the morphogenesis and pathogenesis of Candida yeasts first by conducting an in vitro analysis and then, by conducting an experiment on a murine model of oral candidiasis.Materials and MethodsThis experimental study was performed in the Department of Medical Mycology and Parasitology, School of Medicine, in collaboration with the Central Research Laboratory and the Comparative Biomedical Center, Shiraz University of Medical Sciences (Shiraz, Iran), from September 2017 to October 2018. Determination of the Antifungal ActivityPreparation of MicroorganismsThe antifungal activities of S. thermophilus against several American Type Culture Collection (ATCC) and CentraalBureau voor Schimmelcultures (CBS) strains of Candida, comprising C. albicans (CBS 562, 1905, 1912, 1949, 2730, and 5982), C. tropicalis (ATCC 750), C. krusei (ATCC 6258), C. glabrata (ATCC 90030), C. parapsilosis (ATCC 4344), and C. dubliniensis (CBS 8501), together with three clinical azole-resistant strains of C. albicans, were investigated in this study. S. thermophilus (PTCC 1738) was obtained from the Persian Type Culture Collection (PTCC) as a freeze-dried powder and cultivated in the de Man, Rogosa, and Sharpe (MRS) broth medium (Merck, Germany) at 37 &,deg C in an anaerobic incubator (5% CO2) for 24 hours. The cells were harvested by centrifugation (Labnet, Korea) at 2000&,times g for five minutes, and washed twice in phosphate-buffered saline (PBS Merck, Germany) 0.8% (w/v), NaCl 0.02% (w/v) (Merck, Germany), KH2PO4 0.31% (w/v) (Merck, Germany), Na2HPO4+12H2O 0.02% (w/v) (Merck, Germany), and KCl pH 7.2 (Panreac, Spain). The bacterial cells were resuspended in sterile distilled water and freeze-dried for quantification purposes. 8, Additionally, cell-free supernatants were prepared by growing S. thermophilus in sterile falcon tubes (SPL Life Sciences Co., South Korea) containing 10 mL of the brain heart infusion broth (Merck, Germany), and the supernatant was collected by centrifugation (Labnet, Korea) at 17500&,times g for 10 minutes and sterilized by passage through a 0.2-&,micro m filter (Control Biogene, Spain). 25, Antimicrobial Susceptibility TestsThe antifungal susceptibility test was performed using the broth microdilution method in accordance with the reference method of the Clinical and Laboratory Standards Institute (CLSI document M27-A3). To that end, 100 &,mu L of S. thermophilus serial dilutions (1&,ndash 512 &,mu g/mL) were prepared in 96-well microtiter plates using the Roswell Park Memorial Institute (RPMI-1640) medium (Sigma, St. Louis, MO, USA) and then buffered with 3-morpholinopropane-1-sulfonic acid (MOPS) (Sigma, St. Louis, MO, USA). The Candida strains were suspended in the RPMI-1640 medium, and cell densities were adjusted to 0.5 McFarland at a 530-nm wavelength using the spectrophotometric method (1&,ndash 5&,times 106 colony-forming units [CFU]/mL). The working inocula were diluted at a ratio of 1,1000 with the buffered RPMI-1640 medium. After the addition of100 &,mu L of the working inocula to the wells, the microtiter plates were incubated in a humid atmosphere at 37 &,deg C for 48 hours. Uninoculated media (200 &,mu L) were included as a sterility control (blank). Fluconazole (Sigma, St. Louis, MO, USA), ranging from 0.125 to 128 &,mu g/mL, was used as a positive control. In addition, growth controls (media with inocula but without S. thermophilus) were also included. Minimum inhibitory concentrations were visually determined and reported as the lowest concentration of S. thermophiles, which produced a minimum of 90% growth inhibition in comparison with the growth in the control wells. Each experiment was performed in triplicate. 25, Determination of the Antibiofilm ActivityBiofilm Preparation and GrowthFirst, 100 &,micro L of S. thermophilus serial dilutions (0.5 to 256 &,mu g/mL) were prepared in 96-well microtiter plates using the RPMI-1640 medium. Standard strains of C. albicans (CBS 5982) and C. dubliniensis (CBS 8501) were cultured on Sabouraud dextrose agar (Merck, Germany) plates. After 48 hours, one colony of each yeast was transferred to Erlenmeyer flasks, containing 20 mL of the Sabouraud dextrose broth, and was incubated overnight at 37 &,deg C on an orbital shaker at 100 rpm under aerobic conditions. The harvested yeast cells were washed twice in sterile PBS and resuspended in the RPMI-1640 medium buffered with MOPS (Sigma, St. Louis, MO, USA). The cell concentrations were adjusted to match the turbidity of a 0.5 McFarland standard at a 530-nm wavelength. After dilution at a ratio of 1,1000, 100 &,mu L of the working inocula was added to the wells, and the microtiter plates were then incubated at 37 &,deg C for 48 hours in a humid atmosphere. Next, 200 &,micro L of the uninoculated medium was used as the negative control (blank), and the RPMI-1640 medium with the yeasts, but without the probiotic bacterium, was considered the positive control. 26, Assessment of Biofilm FormationThe extent of biofilm formation was assayed using the (2, 3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide) (XTT) reduction assay. 26, XTT (Sigma Chemical Co, St. Louis, USA) was prepared as a saturated solution with the final concentration of 0.5 mg/mL in Ringer&,rsquo s lactate (Merck, Germany). The solution was filter-sterilized with a 0.22-&,mu m-pore-size filter (Control Biogene, Spain), divided into aliquots, and then stored at -70 &,deg C until further usage. Prior to each assay, the defrosted XTT stock solution was mixed with a menadione sodium bisulfite solution (10 mM prepared in distilled water, Sigma Chemical Co, St. Louis, USA) to reach the concentration of 1 &,micro M. After 48 hours, the biofilms were washed twice with sterile PBS to remove the non-adherent cells, and a 100-&,mu L aliquot of the XTT-menadione was added to each well. The plates were then incubated at 37 &,deg C for two hours in a dark room. Finally, the colorimetric changes were measured at 570 nm using a microplate reader (BMG Labtech, Germany). 26, In vitro Assay of Germ-tube Formation and the Mycelial Growth of C. albicans and C. dubliniensisGerm-tube Formation AnalysisSerial dilutions of freeze-dried S. thermophilus were prepared in 96-well cell-culture plates to reach concentrations of 1 to 512 &,mu g/mL. C. albicans (CBS 5982) and C. dubliniensis (CBS 8501) were separately added to the RPMI-1640 medium enriched with sheep serum to reach the concentration of 0.5 McFarland. Afterwards, 100 &,mu L of a working inoculum made by a 1,1000 dilution of yeast suspension was inoculated into each well, and the plates were incubated at 37 &,deg C in for three hours. After staining was done with Calcofluor White (Sigma, USA), the germ-tube formation was measured under a fluorescence microscope (Olympus, USA). 8, Mycelial Growth AnalysisThe analysis of mycelial growth inhibition by S. thermophilus was also carried out similar to the germ-tube formation analysis, but with a longer incubation period (i.e., 24 hours). 8, An Experimental Model of Oral Candidiasis Inducing Oral Candidiasis All the animal experiments in the current study were carried out in accordance with the principles of the Declaration of Helsinki and the Guide for the Care and Use of Laboratory Animal, approved by Shiraz University of Medical Sciences (IR.SUMS.REC.1396.S591). 27, Thirty female BALB/c mice (age=6 weeks and weight=22&,ndash 25 g) were used for this experimental study. The mice were randomized (simple randomization) and kept in cages housing five animals in pathogen-free conditions. The animals were fed with autoclave-sterilized dried food and water during the experiments. The photoperiods were adjusted to the 12-hour light/dark cycle, and the environmental temperature was maintained at 26 &,deg C. Oral candidiasis was induced in keeping with a study by Ishijima and colleagues, 8, with some modifications. In brief, 15 mg/mL of tetracycline hydrochloride (Hakim Pharmaceutical Company, Iran) was administered through drinking water to the mice for 24 hours. Next, an immunosuppressed condition was induced via a subcutaneous injection of 100 mg/kg of prednisolone (Hakim Pharmaceutical Company, Iran) 24 hours prior to the oral inoculation of C. albicans. Subsequently, the oral cavity of the animals was inoculated with a cotton swab (Talaye Teb Azma Company, Iran) soaked in 2.0&,times 108 CFU/mL of C. albicans (CBS1912). Based on the difference in the number of yeasts grown from the swabs before and after the inoculation, the number of yeasts in the oral cavity of the mice was estimated to be 1&,times 106 CFU per mouse. 8, Probiotic TreatmentThe sample size calculation was done usingn=1+2C(s/d)2 formula, where s is the standard deviation, d is the difference to be detected, and c is a constant dependent on the values of the significance level and the power selected. 28, According to the results of the study by Ishijima and colleagues 8, and the pilot study, the standard deviation of the variables and the magnitude of difference were considered to be 0.3 and 0.7, respectively. With a power of 90% and a significance level of 5% (C=10.51), the sample size was calculated to be comprised of five mice in each group and 30 mice for the whole study. The mice were divided into three groups of probiotics (n=20), fluconazole (n=5), and negative control (n=5). In the probiotic group, 50 &,micro L of S. thermophilus in different concentrations (7.5, 15, 30, and 60 mg/mL) was administered into the oral cavity at five-time points of 24 and 3 hours before and 3, 24, and 27 hours after C. albicans inoculation. Moreover, the same volume of fluconazole (Sigma 2 mg/mL) and distilled water was orally administered to the fluconazole and control groups, respectively. The animals were sacrificed 48 hours after the inoculation for further experiments.Evaluating the Number of Viable Candida CellsThe oral cavity (i.e., the cheek, tongue, and soft palate) was completely swabbed 48 hours after the inoculation, using a fine-tipped cotton swab (Talaye Teb Azma Company, Iran). The cotton end was cut off and placed in a falcon tube, containing 3 mL of sterile saline. Then, the cells were suspended using a vortex mixer (Behdad, Iran), and 50 &,micro L of each sample diluted with a series of 20-fold and 100-fold was cultured on a Sabouraud dextrose agar plate for 24 hours at 37 &,deg C. Finally, the Candida cells were counted, and the CFU per swab was reported as the number of the log10 CFU of Candida per swab.Histopathological Evaluation The tongues of the mice were excised, fixed in 4% paraformaldehyde (pH 7.4), dehydrated by ethanol series, and embedded in paraffin. The yielded paraffin blocks were then sectioned along the longitudinal centerline (5-&,mu m thickness). The corresponded slides were deparaffinized by xylene, rehydrated by ethanol series, and finally stained with periodic acid Schiff (PAS) and hematoxylin and eosin (H &,amp E). Finally, the slides were evaluated by a pathologist to detect any infection. 8, Statistical AnalysisThe data were analyzed with the SPSS software, version 25, (IBM, Chicago, USA). The values from the in vitro studies were reported as the mean&,plusmn SD of the three independent experiments. The statistical analyses between the mice treated with different concentrations of S. thermophilus and the control group were done using the one-way analysis of variance (ANOVA) test, followed by the Tukey honestly significant difference (HSD) post hoc test. A P value of less than 0.05 was considered statistically significant. ResultsAntifungal Activities of the Probiotic BacteriumThe potential of S. thermophilus to inhibit Candida species growth was tested using the broth microdilution method. Our results showed that S. thermophilus exhibited inhibitory activity against selected standard strains of Candida species at concentrations ranging from 16 to 512 &,mu g/mL (geometric mean=141.32 &,mu g/mL). Moreover, this probiotic bacterium inhibited the growth of azole-resistant clinical strains at concentrations of 256 to 512 &,mu g/mL (table 1,).SpeciesATCC/CBSS. thermophilus MIC (&,micro g/mL)Fluconazole MIC (&,micro g/mL)C. albicansCBS 5621280.25C. albicansCBS 19052560.25C. albicansCBS 1912161C. albicansCBS1949640.5C. albicansCBS 27302561C. albicansCBS 59822560.25C. glabrataATCC 900302561C. tropicalisATCC 7502562C. parapsilosisATCC 4344320.25C. kruseiATCC 6258642C. dubliniensisCBS 8501641C. albicansSUMS-8808*512128C. albicansSUMS-2302*25664C. albicansSUMS-625*512128The azole-resistant clinical strains CLSI-M27-A3, Clinical and Laboratory Standards Institute reference method (document M27-A3) ATCC, American Type Culture Collection CBS, CentraalBureau voor Schimmelcultures SUMS, Shiraz University of Medical Science MIC, Minimum inhibitory concentration C. albicans, Candida Albicans |